Equities

LungLife AI Inc

LLAI:LSE

LungLife AI Inc

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)11.50
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change-87.57%
  • Beta--
Data delayed at least 20 minutes, as of Sep 26 2024 10:27 BST.
More ▼

Profile data is unavailable for this security.

About the company

LungLife AI, Inc. is a developer of clinical diagnostic solutions for lung cancer. The Company is engaged in the development and commercialization of its lung cancer early detection test. Using a minimally invasive blood draw, its LungLB test is designed to deliver additional information to clinicians who are evaluating indeterminate lung nodules. LungLB is a blood-based liquid biopsy assay that uses fluorescence in situ hybridization (FISH) and image analysis to identify circulating genetically abnormal cells (CGAC), which include circulating tumor cells (CTCs). The technique incorporates an artificial intelligence (AI)-derived image analysis strategy to identify unique cell populations reflective of the disease state under interrogation.

  • Revenue in GBP (TTM)21.69k
  • Net income in GBP-3.34m
  • Incorporated2009
  • Employees15.00
  • Location
    LungLife AI Inc2545 W. Hillcrest Drive, Suite 140THOUSAND OAKS 91320United StatesUSA
  • Phone+1 (805) 409-9868Fax+1 (805) 855-2003
  • Websitehttps://lunglifeai.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
ValiRx Plc9.60k-2.04m2.62m8.002.62m8.00
TheraCryf PLC396.00k-3.14m2.93m9.002.93m9.00
Fusion Antibodies PLC1.14m-2.23m3.36m31.003.36m31.00
IXICO PLC6.00m-1.87m4.49m89.004.49m89.00
ImmuPharma PLC-69.96k-2.46m6.28m5.006.28m5.00
Genflow Biosciences PLC0.00-1.63m7.44m5.007.44m5.00
Synairgen plc0.00-6.92m7.67m36.007.67m36.00
Cizzle Biotechnology Holdings PLC0.00-1.72m7.75m67.007.75m67.00
LungLife AI Inc21.69k-3.34m8.50m15.008.50m15.00
Oxford Biodynamics PLC617.00k-11.11m11.91m45.0011.91m45.00
OptiBiotix Health PLC644.00k-2.04m16.53m5.0016.53m5.00
Hemogenyx Pharmaceuticals PLC0.00-6.69m20.67m17.0020.67m17.00
Data as of Sep 26 2024. Currency figures normalised to LungLife AI Inc's reporting currency: UK Pound GBX

Institutional shareholders

12.70%Per cent of shares held by top holders
HolderShares% Held
Unicorn Asset Management Ltd.as of 31 Aug 20241.75m6.87%
Lombard Odier Asset Management (Europe) Ltd.as of 22 Mar 20241.27m4.98%
SVM Asset Management Ltd.as of 31 Dec 2023218.75k0.86%
Data from 30 Jun 2024 - 31 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.